IP Library Assignment 059721/0849
Patent Assignment
Reel/Frame 059721/0849

Assignment of Assignor's Interest

Recorded: 2022-04-15 Pages: 26
Assignor
HORIZON PHARMA RHEUMATOLOGY LLC
Executed: 2020-03-31
Assignee
HORIZON THERAPEUTICS USA, INC.
150 SOUTH SAUNDERS ROAD, LAKE FOREST, ILLINOIS, 60045
Covered Property (1)
Variant Forms of Urate Oxidase and Use Thereof
Application: 16/911,074 →
Publication: US 2021/0079362
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Assignment of Assignor's Interest Nov 17, 2021
From: HARTMAN, JACOB; MENDELOVITZ, SIMONA
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 058137/0157 →
Assignment of Assignor's Interest Nov 17, 2021
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 058171/0087 →
Change of Name Nov 17, 2021
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA USA RHEUMATOLOGY LLC
Reel/Frame 058171/0141 →
Change of Name Nov 17, 2021
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 058176/0421 →
Release of Security Interest Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →